Xcellerex(美国)

Xcellerex

美国Xcellerexwww.xcellerex.com总部位于马萨诸塞州的Xcellerex拥有135名雇员，其营收大约为5000万美元。该公司获得的风险资本投资包括KleinerPerkinsCaufield&Byers、VantagePointVenturePartners和SCGCapital。2012年GEHealthcare收购Xcellerex Xcellerexisrevo lutionizingthewaybiomoleculesaredeveloped,manufacturedandcommercialized.Xcellerexisbuiltaroundauniquebiomanufacturingplatformthatfeaturestheinnovativeapplicationofsingle-usecomponenttechnology.TheXcellerexplatformtransformsbiomanufacturingeconomicsbyenabling:Fasterdeploymentofnewmanufacturingcapacity:12-18monthsvs.3-5years.Reducedcapitalinvestment:Typicalsavingsof50%to70%comparedtoconventionalapproaches.Unmatchedflexibility:Modularmicroenvironmentapproachenablesfast,low-costredeploymentformulti-drugproduction.Xcellerexoffersasuiteofworld-classproductsandservicestosupporttheadoptionofitsplatfor